Private Weight Loss Injections Online UK | Cured Pharmacy
Order Private Weight Loss Injections Online UK
Takes less than 2 minutes to complete 100% online
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen
Wegovy (Semaglutide) Weight Loss Injection
Wegovy® Oral Tablets (Semaglutide Pill): PRE-ORDER
Order Private Weight Loss Injections Online UK
Published on: June 03, 2026
Accessing private weight loss injections online UK has never been more straightforward. At Cured Pharmacy, UK-registered prescribers assess your suitability for clinically proven treatments including Mounjaro, Wegovy, and Saxenda—all from the privacy of your home with transparent pricing from £135.00 and discreet next-day delivery across the UK.
How Private Weight Loss Injections Online UK Work
Private weight loss injections available in the UK belong to a class of medications called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and blood sugar control [1]. These prescription treatments work by slowing gastric emptying, reducing hunger signals to the brain, and improving how your body processes glucose—mechanisms that support sustainable weight reduction when combined with dietary modifications.
Clinical evidence demonstrates substantial efficacy across different formulations. In the STEP trials, semaglutide (the active ingredient in Wegovy) produced an average body weight reduction of 14.9% over 68 weeks in adults with obesity [2]. More recently, tirzepatide (Mounjaro) achieved even greater results in the SURPASS-1 trial, with participants losing an average of 22.5% body weight over 72 weeks on the highest dose—the most significant weight reduction observed in any GLP-1 trial to date [3].
At Cured Pharmacy, all weight loss injections require a clinical assessment by our UK-registered prescribers before dispensing. This ensures the treatment aligns with MHRA guidelines and your individual health profile, including contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1].
Mounjaro (Tirzepatide): Dual-Action Weight Loss Treatment
Mounjaro represents a significant advancement in weight management pharmacotherapy as the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [3]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing enhanced metabolic effects that translate to superior weight reduction outcomes in clinical trials.
The medication is administered as a once-weekly subcutaneous injection using the KwikPen device, starting at 2.5mg and titrating gradually to a maintenance dose of 5mg, 10mg, or 15mg based on individual response and tolerability. This dose escalation protocol, recommended by NICE guidance, minimises gastrointestinal side effects commonly associated with GLP-1 therapies [4].
Mounjaro is priced from £135.00 at Cured Pharmacy, representing competitive UK pricing for this advanced dual-agonist formulation. Your final cost depends on the prescribed maintenance dose determined by your UK prescriber during your free online consultation, which typically takes under three minutes to complete.
Who Can Use Mounjaro?
Mounjaro is licensed in the UK for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Your prescriber will assess your medical history, current medications, and weight management goals to determine suitability during your confidential consultation.
Wegovy (Semaglutide): Clinically Proven GLP-1 Injection
Wegovy contains semaglutide, a GLP-1 receptor agonist with extensive clinical validation across the STEP trial programme involving over 4,500 participants [2]. Administered once weekly via pre-filled FlexTouch pen, semaglutide works by reducing appetite, slowing gastric emptying, and improving glycaemic control—mechanisms that support gradual, sustained weight reduction when combined with lifestyle interventions.
The treatment follows a structured dose escalation schedule, beginning at 0.25mg weekly and increasing every four weeks to the maintenance dose of 2.4mg. This gradual titration significantly reduces the incidence of nausea and vomiting, the most commonly reported side effects in clinical trials [2]. Most patients achieve therapeutic response within 16-20 weeks, though individual timelines vary based on adherence and metabolic factors.
Wegovy is available from £135.00 at Cured Pharmacy, with transparent pricing displayed before your consultation. All prescriptions are dispensed by our GPhC-registered pharmacy (9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensuring you receive genuine UK-licensed medication with full regulatory traceability.
Wegovy vs Mounjaro: Understanding the Differences
While both are injectable weight loss treatments licensed by the MHRA, Wegovy activates only the GLP-1 pathway, whereas Mounjaro targets both GIP and GLP-1 receptors. Head-to-head trials suggest tirzepatide produces greater average weight reduction, though individual response varies considerably [3][5]. Your UK prescriber will recommend the most appropriate option based on your medical history, treatment goals, and any contraindications identified during assessment.
| Treatment | Active Ingredient | Frequency | Starting Price |
|---|---|---|---|
| Mounjaro | Tirzepatide (GIP/GLP-1) | Once weekly | From £124.99 |
| Wegovy | Semaglutide (GLP-1) | Once weekly | From £69.00 |
| Saxenda | Liraglutide (GLP-1) | Daily injection | From £68.00 |
| Orlistat | Lipase inhibitor | Three times daily (oral) | From £32.00 |
| Xenical | Orlistat 120mg | Three times daily (oral) | From £32.00 |
Saxenda (Liraglutide): Daily Weight Loss Injection
Saxenda contains liraglutide, an earlier-generation GLP-1 receptor agonist that requires daily subcutaneous injection rather than weekly administration. Licensed in the UK since 2015, liraglutide has an established safety profile with over a decade of clinical use in weight management and glycaemic control [1].
The daily dosing regimen begins at 0.6mg and increases weekly by 0.6mg increments until reaching the maintenance dose of 3.0mg. This frequent administration schedule may suit patients who prefer smaller, more regular doses or have experienced tolerability issues with longer-acting formulations. Clinical trials demonstrated an average weight reduction of 8% over 56 weeks in participants using Saxenda alongside reduced-calorie diet and increased physical activity [6].
Priced from £135.00 at Cured Pharmacy, Saxenda offers an accessible entry point for patients beginning their weight management journey under medical supervision. The medication is supplied in pre-filled multi-dose pens with dose selector, allowing precise adjustment during the titration phase.
Oral Weight Loss Treatments: Orlistat and Alternatives
For patients who prefer oral medication over injections, Orlistat presents a clinically validated alternative with a different mechanism of action. As a gastrointestinal lipase inhibitor, Orlistat blocks approximately 30% of dietary fat absorption in the intestines, reducing overall caloric intake when combined with a reduced-fat diet [7]. Unlike GLP-1 therapies, Orlistat does not affect appetite signalling or hormonal pathways.
Available in prescription strength (120mg, marketed as Xenical or generic Orlistat) and lower-dose over-the-counter formulations (60mg, marketed as Alli or Orlos), this treatment requires three-times-daily administration with meals containing fat. Clinical trials show an average additional weight loss of 2.9kg compared to diet alone over 12 months [7].
Orlistat is priced from £135.00 at Cured Pharmacy for generic formulations, with branded Xenical available from £135.00. The medication suits patients with BMI ≥30 kg/m² or ≥28 kg/m² with comorbidities, though gastrointestinal side effects—including oily stools and faecal urgency—occur more frequently when dietary fat intake exceeds recommended levels.
Choosing Between Injectable and Oral Treatments
Injectable GLP-1 therapies typically produce greater average weight reduction than Orlistat but require subcutaneous administration and carry different side effect profiles [2][7]. Oral treatments offer convenience for needle-averse patients and have been available longer, providing extensive real-world safety data. Your UK prescriber will discuss these factors during your consultation to identify the most suitable option for your circumstances and preferences.
How to Order Private Weight Loss Injections Online UK from Cured Pharmacy
Ordering prescription weight loss treatments through Cured Pharmacy follows a straightforward, clinically governed process designed to meet MHRA and GPhC regulatory standards. Begin by selecting your preferred treatment and clicking 'Start Assessment' to access our secure online consultation platform. The clinical questionnaire takes under three minutes to complete and covers your medical history, current medications, weight management goals, and any contraindications.
A UK-registered prescriber reviews your assessment, typically within 24 hours on weekdays. If approved, your prescription is electronically transmitted to our GPhC-registered pharmacy (9012511), where Superintendent Pharmacist Tarun Kumar and our dispensing team prepare your medication for dispatch. All treatments are shipped in 100% discreet packaging via tracked courier, with most orders delivered next-day across mainland UK.
Transparent pricing is displayed before you begin your consultation—no hidden fees or surprise charges at checkout. Payment is processed securely, and you'll receive email confirmation with tracking details once your order is dispatched. Our clinical team remains available via phone (+44 116 4646009) throughout your treatment journey for any questions regarding administration technique, side effect management, or dose adjustments.
Ongoing Support and Prescription Renewals
Weight loss injections require ongoing prescriber oversight to monitor efficacy, tolerability, and any emerging contraindications. Cured Pharmacy provides streamlined prescription renewal consultations, allowing you to reorder your maintenance dose with minimal administrative burden. Your prescriber may recommend periodic review appointments to assess progress, adjust dosing, or discuss transitioning between treatments based on your response and clinical goals.
Scientific References
- Medicines and Healthcare products Regulatory Agency. (2023). Public Assessment Report: Liraglutide 6 mg/ml solution for injection in pre-filled pen. GOV.UK. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
- National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity [TA1003]. NICE. https://www.nice.org.uk/guidance/ta1003 [accessed 13 August 2026]
- Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
- Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
- Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to prescribed treatment alongside dietary and lifestyle modifications.
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.